125516 Guide

Post-marketing requirements (PMR) for this BLA included the establishment and qualification of a Working Cell Bank (WCB) to ensure consistent production quality. 2. Technical & Hardware: Linear Technology DC1255A

It requires a 7V-9V DC input and uses specialized software like QuickEval-II (Pscope.exe) for data collection and analysis. 3. Legal & Intellectual Property: Case T 1255/16 125516

In the field of electrical engineering, refers to a specific demonstration circuit for 16-bit analog-to-digital converters (ADCs). Device: DC1255A is a 16-bit demonstration circuit. Post-marketing requirements (PMR) for this BLA included the

, with the Biologics License Application (BLA) number 125516 , is an orphan drug developed by United Therapeutics . , with the Biologics License Application (BLA) number

It is specifically indicated for the treatment of pediatric patients with high-risk neuroblastoma .

125516 is also a postal code (PIN code) in Russia , specifically within the Moscow region.

It is typically administered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA).